Cilostazol improves hippocampus-dependent long-term memory in mice

Psychopharmacology

Volumn 231, Issue 13, 2014, Pages 2681-2693

  Yanai, Shuichi ^a   Semba, Yuki ^a   Ito, Hideki ^b   Endo, Shogo ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Cilostazol; CREB phosphorylation; Memory; Pharmacokinetics; Phosphodiesterase 3 inhibitor

Indexed keywords

CILOSTAZOL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PHOSPHODIESTERASE III INHIBITOR; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DENTATE GYRUS; DRUG BLOOD LEVEL; DRUG EFFICACY; FOOTSHOCK; FORCED SWIM TEST; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; LEARNING; LONG TERM MEMORY; MALE; MEMORY CONSOLIDATION; MENTAL TASK; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT TERM MEMORY; SPATIAL MEMORY; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; ASSOCIATION; C57BL MOUSE; DRUG EFFECTS; FEAR; HIPPOCAMPUS; MAZE TEST; METABOLISM; ORAL DRUG ADMINISTRATION; PHOSPHORYLATION;

ADMINISTRATION, ORAL; ANIMALS; BEHAVIOR, ANIMAL; CUES; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DENTATE GYRUS; FEAR; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY, LONG-TERM; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; PHOSPHODIESTERASE 3 INHIBITORS; PHOSPHORYLATION; TETRAZOLES;

EID: 84903301053     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3442-4     Document Type: Article

References (78)

1. Ahn CW, Lee HC, Park SW, Song YD, Huh KB, Oh SJ, Kim YS, Choi YK, Kim JM, Lee TH (2001) Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 52:45-53 (Pubitemid 32143687)
2. Akiyama H, Kudo S, Shimizu T (1985) The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man. Arzneimittelforschung 35:1124-1132 (Pubitemid 15030825)
3. Amaral D, Lavenex P (2006) Hippocampal neuroanatomy. In: Andersen P, Morris R, Amaral D, Bliss T, O'Keefe J (eds) The hippocampus book. Oxford University Press, New York, pp 37-114
4. Anagnostaras SG, Maren S, Fanselow MS (1999) Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: within-subjects examination. J Neurosci 19:1106-1114 (Pubitemid 29066171)
5. Arai H, Takahashi T (2009) A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study. Am J Geriatr Psychiatry 17:353-354
6. Bach ME, Barad M, Son H, Zhuo M, Lu YF, Shih R, Mansuy I, Hawkins RD, Kandel ER (1999) Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal longterm potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc Natl Acad Sci U S A 96:5280-5285 (Pubitemid 29214574)
7. Bartsch D, Ghirardi M, Skehel PA, Karl KA, Herder SP, Chen M, Bailey CH, Kandel ER (1995) Aplysia CREB2 represses long-term facilitation: relief of repression converts transient facilitation into longterm functional and structural change. Cell 83:979-992 (Pubitemid 26006539)
8. Bliss TV, Collingridge GL (1993) A synaptic model of memory: longterm potentiation in the hippocampus. Nature 361:31-39 (Pubitemid 23020772)
9. Bliss TV, Lomo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232:331-356
10. Blokland A, Geraerts E, BeenM(2004)A detailed analysis of rats' spatial memory in a probe trial of a Morris task. Behav Brain Res 154:71-75 (Pubitemid 39070454)
11. Blokland A, Schreiber R, Prickaerts J (2006) Improving memory: a role for phosphodiesterases. Curr Pharm Des 12:2511-2523
12. Boccia MM, Blake MG, Krawczyk MC, Baratti CM (2011) Sildenafil, a selective phosphodiesterase type 5 inhibitor, enhances memory reconsolidation of an inhibitory avoidance task in mice. Behav Brain Res 220:319-324
13. Boess FG, Hendrix M, van der Staay FJ, Erb C, Schreiber R, van Staveren W, de Vente J, Prickaerts J, Blokland A, Koenig G (2004) Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology 47:1081-1092 (Pubitemid 39535847)
14. Borlikova G, Endo S (2009) Inducible cAMP early repressor (ICER) and brain functions. Mol Neurobiol 40:73-86
15. Brightwell JJ, Smith CA, Neve RL, Colombo PJ (2007) Long-term memory for place learning is facilitated by expression of cAMP response element-binding protein in the dorsal hippocampus. Learn Mem 14:195-199 (Pubitemid 46495201)
16. Burgers PM, Eckstein F, Hunneman DH (1979) Stereochemistry of hydrolysis by snake venom phosphodiesterase. J Biol Chem 254:7476-7478
17. Cone J, Wang S, Tandon N, Fong M, Sun B, Sakurai K, Yoshitake M, Kambayashi J, Liu Y (1999) Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol 34:497-504 (Pubitemid 29446916)
18. Croom KF, Dhillon S (2011) Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer. Drugs 71:2213-2229
19. Cuadrado-Tejedor M, Hervias I, Ricobaraza A, Puerta E, Pérez-Roldán JM, García-Barroso C, Franco R, Aguirre N, García-Osta A (2011) Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease. Br J Pharmacol 164:2029-2041
20. Davis RL (1996) Physiology and biochemistry of Drosophila learning mutants. Physiol Rev 76:299-317
21. Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr (1998) Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, doubleblind trial. Circulation 98:678-686 (Pubitemid 28387495)
22. Dooley M, Lamb HM (2000) Donepezil: a review of its use in Alzheimer 's disease. Drugs Aging 16:199-226 (Pubitemid 30166921)
23. Florian C, Mons N, Roullet P (2006) CREB antisense oligodeoxynucleotide administration into the dorsal hippocampal CA3 region impairs long- but not short-term spatial memory in mice. Learn Mem 13:465-472 (Pubitemid 44157472)
24. Fujioka T, Fujioka A, Duman RS (2004) Activation of cAMP signaling facilitates the morphologicalmaturation of newborn neurons in adult hippocampus. J Neurosci 24:319-328 (Pubitemid 38112363)
25. Futatsugi A, Kato K, Ogura H, Li ST, Nagata E, Kuwajima G, Tanaka K, Itohara S, Mikoshiba K(1999) Facilitation ofNMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3. Neuron 24:701-713
26. Gallagher M, Burwell R, Burchinal M(1993) Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci 107:618-626 (Pubitemid 23259627)
27. Goelet P, Castellucci VF, Schacher S, Kandel ER (1986) The long and the short of long-term memory - a molecular framework. Nature 322:419-422 (Pubitemid 16034014)
28. Goldberg ND, Walseth TF, Stephenson JH, Krick TP, Graff G (1980) 18O-Labeling of guanosine monophosphate upon hydrolysis of cyclic guanosine 3′:5′-monophosphate by phosphodiesterase. J Biol Chem 255:10344-10347
29. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114:1624-1634 (Pubitemid 40385553)
30. Hiramatsu M, Takiguchi O, Nishiyama A, Mori H (2010) Cilostazol prevents amyloid β peptide(25-35)-induced memory impairment and oxidative stress in mice. Br J Pharmacol 161:1899-1912
31. Jung MW, McNaughton BL (1993) Spatial selectivity of unit activity in the hippocampal granular layer. Hippocampus 3:165-182 (Pubitemid 23130073)
32. Kandel ER (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294:1030-1038
33. Kida S (2012) A functional role for CREB as a positive regulator of memory formation and LTP. Exp Neurobiol 21:136-140
34. Kojima N, Borlikova G, Sakamoto T, Yamada K, Ikeda T, Itohara S, Niki H, Endo S (2008) Inducible cAMP early repressor acts as a negative regulator for kindling epileptogenesis and long-term fear memory. J Neurosci 28:6459-6472
35. Kwon SU, Cho YJ, Koo JS, Bae HJ, Lee YS, Hong KS, Lee JH, Kim JS (2005) Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebocontrolled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 36:782-786
36. Lakics V, Karran EH, Boess FG (2010) Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology 59:367-374
37. LeDoux JE (1995) Emotion: clues from the brain. Annu Rev Psychol 46:209-235
38. Lee JH, Park SY, Shin YW, Kim CD, Lee WS, Hong KW (2007) Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunctionwith increased neuroprotection after chronic cerebral hypoperfusion in rats. Brain Res 1185:246-255 (Pubitemid 350166308)
39. Leutgeb JK, Leutgeb S, Moser MB, Moser EI (2007) Pattern separation in the dentate gyrus and CA3 of the hippocampus. Science 315:961-966 (Pubitemid 46281178)
40. Li YF, Huang Y, Amsdell SL, Xiao L, O'Donnell JM, Zhang HT (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34:2404-2419
41. Lu YF, Hawkins RD (2002) Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus. J Neurophysiol 88:1270-1278
42. Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155:315-322 (Pubitemid 32477289)
43. Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109:366-398
44. Maren S, Aharonov G, Fanselow MS (1997) Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res 88:261-274 (Pubitemid 27496322)
45. Mayford M, Kandel ER (1999) Genetic approaches to memory storage. Trends Genet 15:463-470 (Pubitemid 29507046)
46. Monti B, Berteotti C, Contestabile A (2006) Subchronic rolipram delivery activates hippocampal CREB and arc, enhances retention and slows down extinction of conditioned fear. Neuropsychopharmacology 31:278-286 (Pubitemid 43113393)
47. Mori K, Yamashita H, Nagao M, Horiguchi J, Yamawaki S (2002) Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flowand extrapyramidal side effects in schizophrenic patients. Pharmacopsychiatry 35:6-11 (Pubitemid 34135452)
48. Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681-683 (Pubitemid 12096189)
49. Moser DJ, Boles Ponto LL, Miller IN, Schultz SK, Menda Y, Arndt S, Nopoulos PC (2012) Cerebral blood flow and neuropsychological functioning in elderly vascular disease patients. J Clin Exp Neuropsychol 34:220-225
50. Murphy GG, Fedorov NB, Giese KP, Ohno M, Friedman E, Chen R, Silva AJ (2004) Increased neuronal excitability, synaptic plasticity, and learning in aged Kvbeta1.1 knockout mice. Curr Biol 14:1907-1915 (Pubitemid 39464813)
51. Nagakura A, Niimura M, Takeo S (2002) Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Br J Pharmacol 135:1783-1793 (Pubitemid 36132709)
52. Neunuebel JP, Knierim JJ (2012) Spatial firing correlates of physiologically distinct cell types of the rat dentate gyrus. J Neurosci 32:3848-3858
53. O'Donnell ME, Badger SA, Sharif MA, Young IS, Lee B, Soong CV (2009) The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease. J Vasc Surg 49:1226-1234
54. Ota KT, Pierre VJ, Ploski JE, Queen K, Schafe GE (2008) The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase. Learn Mem 15:792-805
55. Park SH, Kim JH, Bae SS, Hong KW, Lee DS, Leem JY, Choi BT, Shin HK (2011) Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation. Biochem Biophys Res Commun 408:602-608
56. Patel DS, Anand IS, Bhatt PA (2012) Evaluation of antidepressant and anxiolytic activity of phosphodiesterase 3 inhibitor - cilostazol. Indian J Psychol Med 34:124-128
57. Pepeu G, Giovannini MG (2009) Cholinesterase inhibitors and beyond. Curr Alzheimers Res 6:86-96
58. Perez-Gonzalez R, Pascual C, Antequera D, Bolos M, Redondo M, Perez DI, Pérez-Grijalba V, Krzyzanowska A, Sarasa M, Gil C, Ferrer I, Martinez A, Carro E (2013) Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease. Neurobiol Aging 34:2133-2145
59. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106:274-285
60. Pratt CM(2001) Analysis of the cilostazol safety database. Am J Cardiol 87:28D-33D
61. Prickaerts J, Sik A, van Staveren WC, Koopmans G, Steinbusch HW, van der Staay FJ, de Vente J, Blokland A (2004) Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem Int 45:915-928 (Pubitemid 39108064)
62. Prickaerts J, Sik A, van der Staay FJ, de Vente J, Blokland A (2005) Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation. Psychopharmacology (Berl) 177:381-390 (Pubitemid 40228285)
63. Puzzo D, Staniszewski A, Deng SX, Privitera L, Leznik E, Liu S, Zhang H, Feng Y, Palmeri A, Landry DW, Arancio O (2009) Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer 's diseasemousemodel. J Neurosci 29:8075-8086
64. Ramirez S, Liu X, Lin PA, Suh J, Pignatelli M, Redondo RL, Ryan TJ, Tonegawa S (2013) Creating a false memory in the hippocampus. Science 341:387-391
65. Reneerkens OA, Rutten K, Steinbusch HW, Blokland A, Prickaerts J (2009) Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl) 202:419-443
66. Rutten K, Lieben C, Smits L, Blokland A (2007) The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat. Psychopharmacology (Berl) 192:275-282 (Pubitemid 46669202)
67. Steele RJ, Morris RG(1999) Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus 9:118-136 (Pubitemid 29196956)
68. Takase H, Hashimoto A, Okutsu R, Hirose Y, Ito H, Imaizumi T, Miyakoda G, Mori T (2007) Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout mice. Arzneimittelforschung 57:185-191 (Pubitemid 46724187)
69. Tota S, Hanif K, Kamat PK, Najmi AK, Nath C (2012) Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function. Psychopharmacology (Berl) 222:185-202
70. van der Staay FJ, Rutten K, Bärfacker L, Devry J, Erb C, Heckroth H, Karthaus D, Tersteegen A, van Kampen M, Blokland A, Prickaerts J, Reymann KG, Schröder UH, Hendrix M (2008) The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents. Neuropharmacology 55:908-918
71. Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83:482-504
72. Warburton EC, Brown MW (2010) Findings from animals concerning when interactions between perirhinal cortex, hippocampus and medial prefrontal cortex are necessary for recognition memory. Neuropsychologia 48:2262-2272
73. Xu Y, Zhang HT, O'Donnell JM(2011) Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders. Handb Exp Pharmacol 204:447-485
74. Yanai S, Okaichi Y, Okaichi H (2004) Long-term dietary restriction causes negative effects on cognitive functions in rats. Neurobiol Aging 25:325-332 (Pubitemid 38220968)
75. Yanai S, Semba Y, Endo S (2012) Remarkable changes in behavior and physiology of laboratory mice after the massive 2011 Tohoku earthquake in Japan. PLoS One 7:e44475
76. Yin JC, Del Vecchio M, Zhou H, Tully T (1995) CREB as a memory modulator: induced expression of a dCREB2 activator isoform enhances long-term memory in Drosophila. Cell 81:107-115
77. Yoo HD, Cho HY, Lee YB (2010) Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1. Br J Clin Pharmacol 69:27-37
78. Yuede CM, Dong H, Csernansky JG (2007) Anti-dementia drugs and hippocampal-dependent memory in rodents. Behav Pharmacol 18: 347-363 (Pubitemid 47356364)